| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:359-364.)
© 1995 American Heart Association, Inc.
Articles |
Endothelin-1 in Pulmonary Hypertension Associated With High-Altitude Exposure
From Internal Medicine, Kantonsspital, Chur, Switzerland (S.G., W.H.R.); the Department of Medicine, Division of Clinical Pharmacology, University Hospital, Basel, Switzerland (M.W., T.F.L.); the Departments of Sports Medicine (P.B., E.H.) and Cardiology (F.N.), University of Heidelberg, Germany; and Stadtspital Triemli, Zürich, Switzerland (O.O.).
Correspondence to W. Reinhart, MD, Internal Medicine, Kantonsspital, CH-7000 Chur, Switzerland.
Background Endothelin-1 is involved in chronic pulmonary hypertension. Its role in acute pulmonary hypertension due to hypoxia in humans is not clear. We therefore studied the influence of hypoxia caused by exposure to high altitude on plasma endothelin-1 levels, arterial blood gases, and pulmonary arterial pressure in subjects taking nifedipine or placebo.
Methods and Results Twenty-two healthy volunteers were investigated at low altitude (490 m) and high altitude (4559 m). Arterial blood gases were analyzed immediately, endothelin-1 was measured by radioimmunoassay, and pulmonary artery pressure was assessed by Doppler echocardiography. After baseline investigations, the mountaineers were allocated in a randomized double-blind fashion to receive either placebo or nifedipine (20 mg TID) during rapid ascent to high altitude within 22 hours. Tests were repeated at the high-altitude research laboratories located in the Capanna "Regina Margherita" (Italy, 4559 m). Plasma endothelin-1 was increased twofold at high altitude (5.9±2.2 pg/mL compared with 2.9±1.1 pg/mL, P<.05), was inversely related to arterial PO2 (r=-.46, P<.001), and correlated with pulmonary artery pressure (r=.52, P<.002). At high altitude, arterial endothelin-1 was lower (4.3±1.6 pg/mL) than venous endothelin-1 (5.9±2.2 pg/mL, P<.001), indicating either predominant production in the venous vasculature or pronounced clearance in the pulmonary circulation. The calcium antagonist nifedipine, which lowered pulmonary artery pressure at high altitude (32±5 versus 42±11 mm Hg, P<.05), had no influence on plasma endothelin-1 levels. The administration of 35% O2 at high altitude normalized arterial PO2, tended to decrease endothelin-1, and decreased pulmonary artery pressure accordingly.
Conclusions We conclude that plasma endothelin-1 is increased at high altitude, but whether or not it represents an important pathogenetic factor for pulmonary hypertension remains to be investigated.
Key Words: endothelin • hypoxia • calcium channels • arteries • pressure
This article has been cited by other articles:
 |
|
 |
|
  A. P. Gomez, M. J. Moreno, R. M. Baldrich, and A. Hernandez Endothelin-1 Molecular Ribonucleic Acid Expression in Pulmonary Hypertensive and Nonhypertensive Chickens Poult. Sci., July 1, 2008; 87(7): 1395 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Lund, L. N. Agbor, N. Zhang, A. Baker, H. Zhao, G. D. Fink, N. L. Kanagy, and M. K. Walker Loss of the Aryl Hydrocarbon Receptor Induces Hypoxemia, Endothelin-1, and Systemic Hypertension at Modest Altitude Hypertension, March 1, 2008; 51(3): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Rubin Endothelin-1 and the Pulmonary Vascular Response to Altitude: A New Therapeutic Target? Circulation, September 26, 2006; 114(13): 1350 - 1351. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Modesti, S. Vanni, M. Morabito, A. Modesti, M. Marchetta, T. Gamberi, F. Sofi, G. Savia, G. Mancia, G. F. Gensini, et al. Role of Endothelin-1 in Exposure to High Altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) Study Circulation, September 26, 2006; 114(13): 1410 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, M. Tong, S. Chinta, J. U. Raj, and Y. Gao Hypoxia-induced reactive oxygen species downregulate ETB receptor-mediated contraction of rat pulmonary arteries Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L570 - L578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Johnson, A. Nohria, L. Garrett, J. C. Fang, J. Igo, M. Katai, P. Ganz, and M. A. Creager Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H568 - H575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Carpenter and K. R. Stenmark Endothelin receptor blockade decreases lung water in young rats exposed to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L547 - L554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dumont, C. Mardirosoff, and M. R Tramèr Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review BMJ, July 29, 2000; 321(7256): 267 - 272. [Abstract] [Full Text]
|
|
|
|
 |
|
 B Prendergast, D E Newby, L E Wilson, D J Webb, and P S Mankad Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery Heart, October 1, 1999; 82(4): 505 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sartori, L. Vollenweider, B.-M. Loffler, A. Delabays, P. Nicod, P. Bartsch, and U. Scherrer Exaggerated Endothelin Release in High-Altitude Pulmonary Edema Circulation, May 25, 1999; 99(20): 2665 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-W. Chen, C.-F. Chen, and Y.-L. Lai Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1543 - H1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, S. Shaw, M. Barton, and T. F. Luscher Losartan but Not Verapamil Inhibits Angiotensin II–Induced Tissue Endothelin-1 Increase : Role of Blood Pressure and Endothelial Function Hypertension, June 1, 1998; 31(6): 1305 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wight, C. F. Kung, P. Moreau, H. Takase, and T. F. Luscher Chronic Blockade of Nitric Oxide-Synthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Pregnancy Outcome Reproductive Sciences, May 1, 1998; 5(3): 132 - 139. [Abstract] [PDF]
|
|
|
|
|
|
K. Stangl, T. Dschietzig, M. Laule, K. Alexiou, K. D. Wernecke, and G. Baumann Pulmonary Big Endothelin Affects Coronary Tone and Leads to Enhanced, ETA-Mediated Coronary Constriction in Early Endothelial Dysfunction Circulation, November 4, 1997; 96(9): 3192 - 3200. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. M. Smith, T. J. Brown, A. G. Roach, K. I. Williams, and B. Woodward Evidence for Endothelin Involvement in the Pulmonary Vasoconstrictor Response to Systemic Hypoxia in the Isolated Rat Lung J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 419 - 425. [Abstract] [Full Text]
|
|
|
|
|
|
G. Noll, R. R. Wenzel, S. de Marchi, S. Shaw, and T. F. Luscher Differential Effects of Captopril and Nitrates on Muscle Sympathetic Nerve Activity in Volunteers Circulation, May 6, 1997; 95(9): 2286 - 2292. [Abstract] [Full Text]
|
|
|
|
|
|
G. Noll, R. R. Wenzel, M. Schneider, V. Oesch, C. Binggeli, S. Shaw, P. Weidmann, and T. F. Luscher Increased Activation of Sympathetic Nervous System and Endothelin by Mental Stress in Normotensive Offspring of Hypertensive Parents Circulation, March 1, 1996; 93(5): 866 - 869. [Abstract] [Full Text]
|
|